Header Logo

Connection

ROBERTO MIRANDA to Dasatinib

Back to Details
This is a "connection" page, showing publications ROBERTO MIRANDA has written about Dasatinib.
ROBERTO MIRANDA
Connection Strength
0.072
Dasatinib
  1. Dasatinib-responsive mast cell neoplasms as initial presentation of chronic myelogenous leukemia in blast phase. J Clin Oncol. 2011 Jun 10; 29(17):e514-6.
    View in: PubMed
    Score: 0.072
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.